Skip to content

SANUWAVE Health, Inc. SNWV Q4 2024 Annual earnings

Reported March 20, 2025 · Before market open

Next report

Aug 14, 2026 (in a month)
Revenue estimate$11.5M
EPS estimate-$0.03

Financials

Q4 2024

Income statement

See full
Revenue$10.3M+47.6%
Gross profit$8.0M+66.3%
Operating income$2.0M
Net income-$13.3M
EPS (diluted)-$1.12+49.3%

Balance sheet

See full
Cash & equivalents$10.2M+470%
Total debt$367.0K
Total equity-$15.8M+64.5%
Total assets$30.1M+34.4%

Cash flow

See full
Operating cash flow$741.0K+158%
CapEx$236.0K+240%
Free cash flow$505.0K+145%

Valuation & ratios

Profitability

See full
Gross margin75.2%+4.8pp
Operating margin11.8%
Net margin-101.4%

Returns & leverage

See full
Current ratio0.4×+0.3×

Segments

By segment

See full
Reportable Segment$10.3M+102%

By product

See full
System revenue$3.9M

Versus estimates

Ask the moment SANUWAVE Health, Inc. reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did SANUWAVE Health, Inc. report Q4 2024 earnings?
SANUWAVE Health, Inc. (SNWV) reported Q4 2024 earnings on March 20, 2025 before market open.
What were SANUWAVE Health, Inc.'s Q4 2024 revenue and EPS?
SANUWAVE Health, Inc. reported revenue of $10.3M and diluted EPS of $-1.21 for Q4 2024.
Where can I find SANUWAVE Health, Inc.'s Q4 2024 SEC filings?
You can read the 10-K periodic report (0001628280-25-014141) directly on SEC EDGAR. The filing index links above go to sec.gov.